Diagnosed with SMM, SPB, or MGUS?
Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
Category Archives for Pre-Myeloma
Diagnostic Testing for MGUS
Whether you “watch and wait” or undergo non-toxic MGUS therapies, regular diagnostic testing is now a part of your life You’ve been diagnosed with monoclonal gammopathy of undetermined
Continue readingMGUS- Whole-Body Hyperthermia, Sauna?
“As hyperthermia is nonmyelosuppressive and can potentiate the tumoricidal effects of radiation, chemotherapy, and immunotherapy, its use as part of a multimodality treatment approach..” I
Continue readingMGUS – Nerve Pain
Peripheral Neuropathy (PN) as Symptom of Monoclonal Gammopathy of Undetermined Significance. “Four statistically significant differences set IgM-MGUS neuropathies apart from IgG-MGUS and IgA-MGUS
Continue readingIncreasing free light chain ratio?
“While FLC ratio ≥100 is associated with a high risk of progression in patients with Smoldering Myeloma, it does not infer an imminent risk of progression…” Hi David- I was diagnosed
Continue readingPre-myeloma, MGUS and Fracture Risk-
Monoclonal Gammopathy of Undetermined Significancer (MGUS) is a blood disorder, not cancer with a higher-risk of bone damage/fractures- While conventional oncology considers all forms of pre-Myeloma to
Continue readingHigh Risk Smoldering Myeloma?
“A markedly elevated serum free light chain (FLC) ratio may serve as a biomarker for malignant transformation in high-risk smoldering multiple myeloma (SMM) and identify patients who are at imminent
Continue readingArthritis, Joint Pain MGUS Symptom, Therapies
“We report nine cases of arthritis/joint pain associated with a monoclonal gammapathy of undermined significance (MGUS). Joint involvement was noted simultaneously or after the diagnosis of monoclonal
Continue readingMGUS, Nerve Pain – Clinical Trial?
“Conclusion: The median survival rate of study patients with MGUS was only slightly shorter than that of a comparable US population.” Hi David- My husband is 59. He was diagnosed with Multiple
Continue readingSmoldering Myeloma- MM stage 1?
“For the 4% of people (MM) who are diagnosed at an early stage, the 5-year survival rate is over 77%. If the cancer has spread to a distant part of the body, the 5-year survival rate is over 54%.
Continue readingSmoldering Multiple Myeloma?
Smoldering multiple myeloma with an increasingly abnormal serum free light chain (FLC) ratio is associated with a higher risk for progression to active multiple myeloma Hi David- I was diagnosed with with
Continue readingMonoclonal Gammopathy of Undetermined Significance (MGUS) Non-toxic Therapies
MGUS is an asymptomatic blood disorder estimated to affect more than 3% of Caucasians over the age of 50 and more than twice that number of African Americans over the age of 50. Many newly-diagnosed
Continue readingPlasmacytoma vs. Multiple Myeloma
What is the difference between a Single Plasmacytoma of bone (SBP) and Multiple Myeloma(MM)? A diagnosis of a single plasmacytoma of bone (SPB), smoldering multiple myeloma (SMM) or monoclonal gammopathy
Continue reading